We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWT icon
2276
iShares MSCI Taiwan ETF
EWT
$11.6B
$1.3M ﹤0.01%
25,790
-4,812
-16% -$268K
AER icon
2277
AerCap
AER
$23.6B
$1.3M ﹤0.01%
31,735
-848
-3% -$39.3K
COMP icon
2278
Compass
COMP
$10.2B
$1.3M ﹤0.01%
359,832
+347,768
+2,883% +$1.9M
JDIV
2279
DELISTED
JPMorgan U.S. Dividend ETF
JDIV
$1.3M ﹤0.01%
41,196
-1,563
-4% -$52.9K
ONEV icon
2280
State Street SPDR Russell 1000 Low Volatility Focus ETF
ONEV
$307M
$1.3M ﹤0.01%
13,236
-2,338
-15% -$243K
BBH icon
2281
VanEck Biotech ETF
BBH
$428M
$1.29M ﹤0.01%
8,859
-975
-10% -$145K
BF.A icon
2282
Brown-Forman Class A
BF.A
$13B
$1.29M ﹤0.01%
19,102
-49
-0.3% -$3.11K
FDIS icon
2283
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.72B
$1.29M ﹤0.01%
21,944
+15,706
+252% +$1.06M
XRN
2284
Chiron Real Estate Inc
XRN
$484M
$1.29M ﹤0.01%
22,996
-4,264
-16% -$287K
EPRF icon
2285
Innovator S&P Investment Grade Preferred ETF
EPRF
$68.6M
$1.29M ﹤0.01%
66,044
+23,553
+55% +$472K
WERN icon
2286
Werner Enterprises
WERN
$2.31B
$1.29M ﹤0.01%
33,442
-409
-1% -$16.1K
IAK icon
2287
iShares US Insurance ETF
IAK
$538M
$1.29M ﹤0.01%
15,528
+13,266
+586% +$1.15M
SSB icon
2288
SouthState Bank Corp
SSB
$10.8B
$1.29M ﹤0.01%
16,700
-2,756
-14% -$215K
ATHM icon
2289
Autohome
ATHM
$2.65B
$1.28M ﹤0.01%
32,664
-14
-0% -$436
NVCR icon
2290
NovoCure
NVCR
$2.02B
$1.28M ﹤0.01%
18,486
-3,327
-15% -$251K
FEP icon
2291
First Trust Europe AlphaDEX Fund
FEP
$534M
$1.28M ﹤0.01%
40,985
-10,320
-20% -$367K
WIW
2292
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$512M
$1.28M ﹤0.01%
121,626
-94,060
-44% -$1.03M
EBIX
2293
DELISTED
Ebix Inc
EBIX
$1.27M ﹤0.01%
75,473
+1,909
+3% +$53.4K
MTG icon
2294
MGIC Investment
MTG
$6.29B
$1.27M ﹤0.01%
100,789
-6,951
-6% -$91.4K
ONEQ icon
2295
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
$1.27M ﹤0.01%
29,388
-4,588
-14% -$219K
SWAV
2296
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$1.27M ﹤0.01%
6,631
+1,987
+43% +$351K
SNBR
2297
DELISTED
Sleep Number
SNBR
$1.27M ﹤0.01%
40,941
-2,566
-6% -$109K
FLNA
2298
Filana Therapeutics
FLNA
$45.7M
$1.27M ﹤0.01%
45,030
-8,577
-16% -$217K
GBF icon
2299
iShares Government/Credit Bond ETF
GBF
$128M
$1.26M ﹤0.01%
11,755
+947
+9% +$103K
LILAK icon
2300
Liberty Latin America Class C
LILAK
$1.67B
$1.26M ﹤0.01%
177,455
-9,620
-5% -$79.8K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.